Pacira | PCRX - Los Gastos De Explotación

Precio De Mercado
23.79
Cambio Diario
-0.03 -0.13%
Mensual
4.21%
Anual
-3.14%
Q2 Expectativa
22.02




Los Gastos De Explotación Cambio Fecha
Assertio Holdings USD 105.8M 12.5M 2025-09
Astellas Pharma JPY 436.66B 16.75B 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Cara Therapeutics USD 5.94M 983K 2025-09
Coherus Biosciences USD 51.83M 2.48M 2025-12
Heron Therapeutics USD 40.55M 1.46M 2025-12
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
J&J USD 18.97B 2.38B 2025-12
Ligand Pharmaceuticals USD 8.29M 32.17M 2025-09
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Novo Nordisk DKK 46.76B 3.99B 2025-12
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 193.68M 27.32M 2025-12
Perrigo USD 1.03B 75.3M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Supernus Pharmaceuticals USD 197.75M 54.54M 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Xoma USD 22.84M 1.67M 2024-09
Zoetis USD 1.55B 3.85B 2025-12